Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

DESOGESTREL AND ETHINYL ESTRADIOL Drug Profile

« Back to Dashboard

What is the patent landscape for Desogestrel And Ethinyl Estradiol, and what generic Desogestrel And Ethinyl Estradiol alternatives are available?

Desogestrel And Ethinyl Estradiol is a drug marketed by Watson Labs, Mayne Pharma, Novast Labs Ltd, Aurobindo Pharma Ltd, Duramed Pharms Barr, and Mylan Labs Ltd. and is included in eight NDAs.

The generic ingredient in DESOGESTREL AND ETHINYL ESTRADIOL is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

Summary for Tradename: DESOGESTREL AND ETHINYL ESTRADIOL

Patents:0
Applicants:6
NDAs:8
Suppliers / Packagers: see list9
Bulk Api Vendors: see list3
Clinical Trials: see list39,561
Patent Applications: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DESOGESTREL AND ETHINYL ESTRADIOL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
DESOGESTREL AND ETHINYL ESTRADIOL
desogestrel; ethinyl estradiol
TABLET;ORAL-28076915-001Jul 29, 2005ABRXNoNo► Subscribe► Subscribe
Mayne Pharma
DESOGESTREL AND ETHINYL ESTRADIOL
desogestrel; ethinyl estradiol
TABLET;ORAL-28077182-001Jan 24, 2006ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
DESOGESTREL AND ETHINYL ESTRADIOL
desogestrel; ethinyl estradiol
TABLET;ORAL-28206853-001Mar 22, 2017ABRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
DESOGESTREL AND ETHINYL ESTRADIOL
desogestrel; ethinyl estradiol
TABLET;ORAL-28202085-001May 20, 2015ABRXNoNo► Subscribe► Subscribe
Mayne Pharma
DESOGESTREL AND ETHINYL ESTRADIOL
desogestrel; ethinyl estradiol
TABLET;ORAL-28076916-001Dec 29, 2008ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot